Nobio develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products.

The company commercializes its antimicrobial technology both through its own products and through partnerships with industry leaders.

Nobios core technology consists of extremely potent particles covered with a high concentration of highly active antimicrobial molecules that kill a wide range of microorganisms (bacteria, viruses, fungi, etc.) on contact.

The Nobio particles can be permanently embedded in, or used as a coating on, many products and materials, providing powerful bioprotection for life.In September 2019, the company received FDA approval to market Infinix, its line of antibacterial products for dental fillings.

In response to COVID-19, Nobio is also implementing its technology in personal protective equipment (PPE) and surface coatings.Nobio is working with several industry leaders to incorporate its technology into their medical, dental, and consumer products.

Nobio also received a grant from the Israeli Innovation Authority for its work on PPE and is involved in discussions with potential partners for commercialization.